TNFRSF4 and type 1 diabetes mellitus: Strikingly we showed a similar upward trend in the frequency of OX-40-expressing 1,25(OH)2D3- or TX527-treated CD4+ T cells from patients with type 1 diabetes (Fig. 3E) even after additional stimulation with such a robust cytokine cocktail.